LCN2 and diabetic kidney disease: In this study, although both biomarkers were independent risk factors for rapid DKD progression, uMCP-1 showed better diagnostic performance than NGAL in terms of prediction, suggesting that uMCP-1 may be a promising biomarker for predicting rapid eGFR decline in DKD patients.